Literature DB >> 19096817

[Glucocorticoids and hypertension].

C Dodt1, J P Wellhöner, M Schütt, F Sayk.   

Abstract

Severe arterial hypertension is a hallmark of Cushing syndrome which occurs in 80% of the patients. Additionally, persistent cortisol excess induces obesity, hyperinsulinemia with disturbed glucose tolerance and dyslipidemia which all contribute to the development of hypertension and its deleterious sequelae. Cortisol effects are mediated through diversely distributed intracellular glucocorticoid and mineralocorticoid receptors which are protected by the 11-beta-hydroxysteroiddehydrogenase type 2 in cells of some organs (i.e. kidney) but not in other. A highly complex clinical picture evolves in case of hypercortisolism due to the ubiquitous distribution of steroid receptors with different affinity and binding capacities for glucocorticoids. The present review focuses on the cortisol induced changes in blood pressure regulation which contribute to the development of hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19096817     DOI: 10.1007/s00108-008-2197-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

Review 1.  11 beta-Hydroxysteroid dehydrogenase.

Authors:  P M Stewart; Z S Krozowski
Journal:  Vitam Horm       Date:  1999       Impact factor: 3.421

2.  Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo.

Authors:  R Best; S M Nelson; B R Walker
Journal:  J Endocrinol       Date:  1997-04       Impact factor: 4.286

3.  Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor.

Authors:  M Montrella-Waybill; J N Clore; A C Schoolwerth; C O Watlington
Journal:  J Clin Endocrinol Metab       Date:  1991-05       Impact factor: 5.958

4.  Pressor responsiveness in corticosteroid-induced hypertension in humans.

Authors:  M Pirpiris; K Sudhir; S Yeung; G Jennings; J A Whitworth
Journal:  Hypertension       Date:  1992-06       Impact factor: 10.190

5.  Gender-related differences in the presentation and course of Cushing's disease.

Authors:  Francesca Pecori Giraldi; Mirella Moro; Francesco Cavagnini
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

Review 6.  Brain corticosteroid receptor balance in health and disease.

Authors:  E R De Kloet; E Vreugdenhil; M S Oitzl; M Joëls
Journal:  Endocr Rev       Date:  1998-06       Impact factor: 19.871

7.  Glucocorticoids increase Ca2+ uptake and [3H]dihydropyridine binding in A7r5 vascular smooth muscle cells.

Authors:  T Hayashi; T Nakai; S Miyabo
Journal:  Am J Physiol       Date:  1991-07

8.  Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells.

Authors:  M Sakaue; B B Hoffman
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

Review 9.  Hypertension and the cortisol-cortisone shuttle.

Authors:  Marcus Quinkler; Paul M Stewart
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

10.  Central nervous system mediates an antihypertensive property in glucocorticoid hypertension in dogs.

Authors:  H Nakamoto; H Suzuki; Y Kageyama; M Murakami; M Naitoh; T Saruta
Journal:  J Hypertens       Date:  1995-10       Impact factor: 4.844

View more
  1 in total

1.  Role of natural herbs in the treatment of hypertension.

Authors:  Nahida Tabassum; Feroz Ahmad
Journal:  Pharmacogn Rev       Date:  2011-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.